Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhipeng,Wang

第一单位： Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

作者： Zhipeng,Wang ^[1] ; Haoyang,Liu ^[1] ; Jinge,Zhao ^[1] ; Junru,Chen ^[1] ; Sha,Zhu ^[1] ; Jindong,Dai ^[1] ; Yuchao,Ni ^[1] ; Nanwei,Xu ^[1] ; Fengnian,Zhao ^[1] ; Ben,He ^[1] ; Xingming,Zhang ^[2] ; Jiayu,Liang ^[1] ; Guangxi,Sun ^[1] ; Zhenhua,Liu ^[1] ; Pengfei,Shen ^[1] ; Hao,Zeng ^[1]

作者单位： Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. ^[1] Department of Urology, The Third People's Hospital of Chengdu, Chengdu, China. ^[2]

DOI 10.21037/atm-2023-7

PMID 37404997

发布时间 2023-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2023年11卷9期

332页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除